Saudi Arabia Point of Care POC Diagnostics Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Saudi Arabia POC Diagnostics Market, valued at USD 490 Mn, grows due to rising chronic diseases, demand for rapid tests, and tech innovations in key cities like Riyadh.

Region:Middle East

Author(s):Geetanshi

Product Code:KRAA0631

Pages:83

Published On:January 2026

About the Report

Base Year 2024

Saudi Arabia Point of Care POC Diagnostics Market Overview

  • The Saudi Arabia Point of Care POC Diagnostics Market is valued at USD 490 million, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, the rising demand for rapid diagnostic tests amid infectious disease outbreaks, and advancements in technology including microfluidics and immunoassays that enhance the accuracy and efficiency of diagnostic procedures.
  • Key cities such as Riyadh, Jeddah, and Dammam dominate the market due to their advanced healthcare infrastructure, high population density, and the presence of major healthcare facilities. These urban centers are also focal points for medical research and development, contributing to the growth of the POC diagnostics sector.
  • The Saudi Food and Drug Authority (SFDA) Medical Devices Regulations, 2022 issued by the SFDA mandate registration and compliance for POC diagnostic devices, requiring manufacturers to meet safety, performance standards, and quality management system certification for import and distribution in primary healthcare settings. This initiative aims to improve patient outcomes by facilitating timely diagnosis and treatment, thereby enhancing the overall efficiency of the healthcare system.
Saudi Arabia Point of Care POC Diagnostics Market Size

Saudi Arabia Point of Care POC Diagnostics Market Segmentation

By Type:The market is segmented into various types of diagnostic devices, each catering to specific healthcare needs. The subsegments include Blood Glucose Monitoring Devices, Infectious Disease Testing Kits, Cardiac Markers Testing Devices, Coagulation Testing Devices, Pregnancy and Fertility Testing Kits, and Others. Among these, Blood Glucose Monitoring Devices are leading the market due to the rising incidence of diabetes and the growing awareness of self-monitoring among patients.

Saudi Arabia Point of Care POC Diagnostics Market segmentation by Type.

By End-User:The end-user segmentation includes Hospitals, Clinics, Home Care Settings, Emergency Medical Services, and Others. Hospitals are the dominant end-user segment, driven by the increasing adoption of POC diagnostics for rapid patient assessment and management, particularly in emergency and critical care settings.

Saudi Arabia Point of Care POC Diagnostics Market segmentation by End-User.

Saudi Arabia Point of Care POC Diagnostics Market Competitive Landscape

The Saudi Arabia Point of Care POC Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton, Dickinson and Company, Cepheid, Alere Inc., Bio-Rad Laboratories, Ortho Clinical Diagnostics, Quidel Corporation, Hologic, Inc., Thermo Fisher Scientific, Medtronic, Sysmex Corporation, Mindray Medical International Limited, Nova Biomedical contribute to innovation, geographic expansion, and service delivery in this space.

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Roche Diagnostics

1896

Basel, Switzerland

Siemens Healthineers

2017

Munich, Germany

Becton, Dickinson and Company

1897

Franklin Lakes, New Jersey, USA

Thermo Fisher Scientific

2006

Waltham, Massachusetts, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Innovation Rate

Saudi Arabia Point of Care POC Diagnostics Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the POC diagnostics market in Saudi Arabia. According to the Saudi Ministry of Health, approximately 8 million people are living with diabetes, and the prevalence is expected to increase by 25% in future. This growing patient population necessitates rapid and accessible diagnostic solutions, thereby boosting demand for POC testing devices.
  • Rising Demand for Rapid Diagnostic Tests:The demand for rapid diagnostic tests is surging, particularly in emergency and primary care settings. In future, the Saudi healthcare sector is projected to allocate over SAR 12 billion towards diagnostic services, with a significant portion directed towards POC testing. This shift is driven by the need for timely decision-making in patient management, especially in rural areas where traditional lab access is limited.
  • Technological Advancements in Diagnostic Devices:Continuous technological innovations are enhancing the capabilities of POC diagnostic devices. In future, the introduction of advanced biosensors and microfluidic technologies is expected to improve test accuracy and reduce turnaround times. The Saudi government is investing SAR 2 billion in health technology initiatives, fostering an environment conducive to the development and adoption of these cutting-edge diagnostic solutions.

Market Challenges

  • High Costs of Advanced Diagnostic Equipment:The high costs associated with advanced POC diagnostic equipment pose a significant challenge for widespread adoption. Many healthcare facilities in Saudi Arabia face budget constraints, with average spending on diagnostic equipment reaching SAR 600 million annually. This financial barrier limits access to the latest technologies, particularly in smaller clinics and rural healthcare settings.
  • Regulatory Hurdles in Product Approvals:Regulatory challenges can delay the introduction of new POC diagnostic devices in the Saudi market. The Saudi Food and Drug Authority (SFDA) has stringent approval processes, which can take up to 14 months. This lengthy timeline can hinder innovation and market entry for new products, impacting the overall growth of the POC diagnostics sector in the region.

Saudi Arabia Point of Care POC Diagnostics Market Future Outlook

The future of the POC diagnostics market in Saudi Arabia appears promising, driven by increasing healthcare investments and a focus on enhancing patient care. The integration of artificial intelligence in diagnostic processes is expected to streamline operations and improve accuracy. Additionally, the expansion of telemedicine services will facilitate remote patient monitoring, further driving the demand for POC testing solutions. As healthcare providers adapt to these trends, the market is likely to witness significant growth and innovation in the coming years.

Market Opportunities

  • Expansion of Telemedicine Services:The growth of telemedicine services presents a unique opportunity for POC diagnostics. With an estimated 35% increase in telehealth consultations expected in future, integrating POC testing can enhance remote patient management, allowing for timely interventions and improved health outcomes.
  • Development of Cost-Effective Diagnostic Solutions:There is a growing demand for cost-effective diagnostic solutions in Saudi Arabia. In future, the market for affordable POC devices is projected to expand significantly, driven by partnerships with local manufacturers. This trend will enable broader access to essential diagnostic tools, particularly in underserved areas.

Scope of the Report

SegmentSub-Segments
By Type

Blood Glucose Monitoring Devices

Infectious Disease Testing Kits

Cardiac Markers Testing Devices

Coagulation Testing Devices

Pregnancy and Fertility Testing Kits

Others

By End-User

Hospitals

Clinics

Home Care Settings

Emergency Medical Services

Others

By Application

Disease Diagnosis

Health Monitoring

Screening

Others

By Distribution Channel

Direct Sales

Online Sales

Retail Pharmacies

Others

By Technology

Lateral Flow Assays

Microfluidics

Molecular Diagnostics

Others

By Region

Central Region

Eastern Region

Western Region

Southern Region

By Policy Support

Government Subsidies

Tax Incentives

Research Grants

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Saudi Food and Drug Authority, Ministry of Health)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Technology Providers

Industry Associations

Financial Institutions

Players Mentioned in the Report:

Abbott Laboratories

Roche Diagnostics

Siemens Healthineers

Becton, Dickinson and Company

Cepheid

Alere Inc.

Bio-Rad Laboratories

Ortho Clinical Diagnostics

Quidel Corporation

Hologic, Inc.

Thermo Fisher Scientific

Medtronic

Sysmex Corporation

Mindray Medical International Limited

Nova Biomedical

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Saudi Arabia Point of Care POC Diagnostics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Saudi Arabia Point of Care POC Diagnostics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Saudi Arabia Point of Care POC Diagnostics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of chronic diseases
3.1.2 Rising demand for rapid diagnostic tests
3.1.3 Technological advancements in diagnostic devices
3.1.4 Government initiatives to enhance healthcare access

3.2 Market Challenges

3.2.1 High costs of advanced diagnostic equipment
3.2.2 Regulatory hurdles in product approvals
3.2.3 Limited awareness among healthcare providers
3.2.4 Competition from traditional laboratory testing

3.3 Market Opportunities

3.3.1 Expansion of telemedicine services
3.3.2 Growing interest in home healthcare solutions
3.3.3 Partnerships with local healthcare providers
3.3.4 Development of cost-effective diagnostic solutions

3.4 Market Trends

3.4.1 Shift towards personalized medicine
3.4.2 Integration of AI in diagnostic processes
3.4.3 Increased focus on preventive healthcare
3.4.4 Rise in point-of-care testing in remote areas

3.5 Government Regulation

3.5.1 Implementation of quality control standards
3.5.2 Guidelines for the approval of POC devices
3.5.3 Regulations on data privacy and patient consent
3.5.4 Policies promoting local manufacturing of diagnostics

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Saudi Arabia Point of Care POC Diagnostics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Saudi Arabia Point of Care POC Diagnostics Market Segmentation

8.1 By Type

8.1.1 Blood Glucose Monitoring Devices
8.1.2 Infectious Disease Testing Kits
8.1.3 Cardiac Markers Testing Devices
8.1.4 Coagulation Testing Devices
8.1.5 Pregnancy and Fertility Testing Kits
8.1.6 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Home Care Settings
8.2.4 Emergency Medical Services
8.2.5 Others

8.3 By Application

8.3.1 Disease Diagnosis
8.3.2 Health Monitoring
8.3.3 Screening
8.3.4 Others

8.4 By Distribution Channel

8.4.1 Direct Sales
8.4.2 Online Sales
8.4.3 Retail Pharmacies
8.4.4 Others

8.5 By Technology

8.5.1 Lateral Flow Assays
8.5.2 Microfluidics
8.5.3 Molecular Diagnostics
8.5.4 Others

8.6 By Region

8.6.1 Central Region
8.6.2 Eastern Region
8.6.3 Western Region
8.6.4 Southern Region

8.7 By Policy Support

8.7.1 Government Subsidies
8.7.2 Tax Incentives
8.7.3 Research Grants
8.7.4 Others

9. Saudi Arabia Point of Care POC Diagnostics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Innovation Rate
9.2.8 Distribution Efficiency
9.2.9 Brand Recognition
9.2.10 Customer Satisfaction Score

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Abbott Laboratories
9.5.2 Roche Diagnostics
9.5.3 Siemens Healthineers
9.5.4 Becton, Dickinson and Company
9.5.5 Cepheid
9.5.6 Alere Inc.
9.5.7 Bio-Rad Laboratories
9.5.8 Ortho Clinical Diagnostics
9.5.9 Quidel Corporation
9.5.10 Hologic, Inc.
9.5.11 Thermo Fisher Scientific
9.5.12 Medtronic
9.5.13 Sysmex Corporation
9.5.14 Mindray Medical International Limited
9.5.15 Nova Biomedical

10. Saudi Arabia Point of Care POC Diagnostics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Defense
10.1.3 Ministry of Education
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Infrastructure Investments
10.2.2 Technology Upgrades
10.2.3 Training and Development
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Clinics
10.3.3 Home Care Providers
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training Needs
10.4.2 Infrastructure Readiness
10.4.3 Technology Acceptance
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Cost Savings Analysis
10.5.2 Patient Outcome Improvements
10.5.3 Scalability of Solutions
10.5.4 Others

11. Saudi Arabia Point of Care POC Diagnostics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of market reports from health organizations and government health ministries
  • Review of published articles and white papers on POC diagnostics trends in Saudi Arabia
  • Examination of regulatory frameworks and guidelines from the Saudi Food and Drug Authority (SFDA)

Primary Research

  • Interviews with healthcare professionals and laboratory managers in hospitals and clinics
  • Surveys targeting medical device distributors and manufacturers operating in the region
  • Focus group discussions with end-users, including physicians and patients, to understand preferences

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including industry reports and expert opinions
  • Triangulation of quantitative data from surveys with qualitative insights from interviews
  • Sanity checks conducted through expert panel reviews comprising industry veterans and academic researchers

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of the overall healthcare expenditure in Saudi Arabia as a baseline for POC diagnostics
  • Segmentation of the market by product type, including glucose meters, infectious disease tests, and cardiac markers
  • Incorporation of government health initiatives promoting the adoption of POC diagnostics

Bottom-up Modeling

  • Collection of sales data from leading POC diagnostic device manufacturers operating in Saudi Arabia
  • Estimation of market penetration rates based on healthcare facility types and patient demographics
  • Volume and pricing analysis to derive revenue estimates for each product segment

Forecasting & Scenario Analysis

  • Utilization of historical growth rates and market trends to project future market size through 2030
  • Scenario analysis based on potential regulatory changes and technological advancements in diagnostics
  • Development of best-case, worst-case, and most-likely scenarios to assess market dynamics

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Laboratories100Laboratory Managers, Clinical Pathologists
Primary Care Clinics80General Practitioners, Nurse Practitioners
Diagnostic Device Distributors60Sales Managers, Product Specialists
Public Health Officials50Health Policy Advisors, Epidemiologists
Patient Focus Groups8Chronic Disease Patients, Caregivers

Frequently Asked Questions

What is the current value of the Saudi Arabia Point of Care (POC) Diagnostics Market?

The Saudi Arabia Point of Care Diagnostics Market is valued at approximately USD 490 million, reflecting a significant growth driven by the increasing prevalence of chronic diseases and the demand for rapid diagnostic tests.

What are the main drivers of growth in the Saudi Arabia POC Diagnostics Market?

Which cities are the primary markets for POC diagnostics in Saudi Arabia?

What types of diagnostic devices are included in the Saudi Arabia POC Diagnostics Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022